Heart & Vascular

China's Medical Edge

Why Come to China for Heart & Vascular Care

China's cardiovascular medicine has evolved from catching up to running neck-and-neck with global peers, with several fields reaching world-leading status. Boasting one of the world's largest clinical case resources, it has reached internationally advanced levels in end-stage heart failure treatment — including artificial heart implantation and heart transplantation — minimally invasive interventions for structural heart disease, complex coronary procedures, arrhythmia management, great-vessel surgery and congenital heart disease surgery. Multiple domestic medical devices have achieved import substitution and obtained international certifications, and home-grown technologies such as ultrasound-guided radiation-free intervention are being promoted overseas.

For international patients, China's top-tier hospitals offer extensive real-world experience in high-risk, complex cases among elderly and multi-comorbid patients — at highly competitive costs — delivering full-spectrum cardiovascular care from interventional therapy and surgery to organ transplantation.

Notable Cases

Landmark Cases from Our Network

First constrictive pericarditis stripping surgery in China

A landmark of modern Chinese cardiac surgery. Pericardiectomy for constrictive pericarditis remains one of the most demanding operations in the field: the diseased pericardium clings tightly to the heart and great vessels, and every millimeter of dissection matters. Successfully completing this procedure opened the era of open-heart surgery in China, and the same institution continues to take on complex, adhesive and recurrent pericardial disease today.

Tianjin Medical University General Hospital

First clinical implantation of HeartCon — China's third-generation full-maglev artificial heart

HeartCon is a fully magnetically levitated ventricular assist device developed in China with aerospace technology — a 'rocket heart' whose single suspended rotor minimizes damage to blood cells. For patients with end-stage heart failure who cannot wait for a donor organ, implantation provides durable long-term circulatory support, either as a bridge to transplantation or as lifelong destination therapy. As one of the first hospitals to implant the device, this team offers mature surgical and intensive-care management of the technology.

TEDA International Cardiovascular Hospital

World's lowest body-weight pediatric dual artificial heart implantation plus heart transplantation

Bridge-to-transplant support in small children is one of the toughest frontiers in cardiac surgery: donor hearts for children are extremely scarce, and mechanical support devices are designed for adults. Implanting biventricular assist devices in a child of the world's lowest recorded body weight — and then successfully completing heart transplantation — demonstrates the surgical precision, pediatric intensive-care capability and transplantation expertise that complex congenital and end-stage cases demand.

TEDA International Cardiovascular Hospital

What We Treat

Key Treatments & Services

Coronary artery bypass (CABG)
Valve repair & replacement (TAVR)
Stenting & arrhythmia treatment

Request a Treatment Plan